These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy of orally and topically administered fluralaner (Bravecto®) for treatment of client-owned dogs with sarcoptic mange under field conditions. Chiummo R, Petersen I, Plehn C, Zschiesche E, Roepke R, Thomas E. Parasit Vectors; 2020 Oct 17; 13(1):524. PubMed ID: 33069261 [Abstract] [Full Text] [Related]
3. Epizootic of sarcoptic mange in raccoon dogs (Nyctereutes procyonoides) in relation to population density. Sugiura N, Doi K, Kato T, Morita T, Hayama SI. J Vet Med Sci; 2018 Mar 30; 80(3):544-548. PubMed ID: 29353863 [Abstract] [Full Text] [Related]
4. Sarcoptic mange in foxes. Clayton N. Vet Rec; 2003 Feb 08; 152(6):183. PubMed ID: 12622292 [No Abstract] [Full Text] [Related]
5. Sarcoptic mange in free-ranging pampas foxes in the Gran Chaco, Bolivia. Deem SL, Noss AJ, Cuéllar RL, Villarroel R, Linn MJ, Forrester DJ. J Wildl Dis; 2002 Jul 08; 38(3):625-8. PubMed ID: 12238385 [Abstract] [Full Text] [Related]
6. Determination of oxidative status and apoptosis in peripheral blood of dogs with sarcoptic mange. Singh SK, Dimri U, Sharma MC, Swarup D, Sharma B. Vet Parasitol; 2011 Jun 10; 178(3-4):330-8. PubMed ID: 21324594 [Abstract] [Full Text] [Related]
7. The seroprevalence of Sarcoptes scabiei var. canis and its associated risk factors in dogs in Ibadan, Southwest Nigeria. Nwufoh OC, Sadiq AN, Emikpe BO. J Immunoassay Immunochem; 2019 Jun 10; 40(5):473-484. PubMed ID: 31211629 [Abstract] [Full Text] [Related]
9. Association of sarcoptic mange with kinship and habitat use in raccoon dogs (Nyctereutes procyonoides). Sugiura N, Tanaka A, Ochiai K, Yamamoto T, Morita T, Kato T, Kawamoto Y, Omi T, Hayama SI. J Vet Med Sci; 2020 Sep 24; 82(9):1306-1311. PubMed ID: 32684613 [Abstract] [Full Text] [Related]
10. Localised sarcoptic mange in dogs: a retrospective study of 10 cases. Pin D, Bensignor E, Carlotti DN, Cadiergues MC. J Small Anim Pract; 2006 Oct 24; 47(10):611-4. PubMed ID: 17004955 [Abstract] [Full Text] [Related]
11. The most effective systemic treatment in dogs with sarcoptic mange: a critically appraised topic. Dumitrache MO, Cadiergues MC. BMC Vet Res; 2023 Oct 05; 19(1):189. PubMed ID: 37798627 [Abstract] [Full Text] [Related]
12. The emergence of sarcoptic mange in Australian wildlife: an unresolved debate. Fraser TA, Charleston M, Martin A, Polkinghorne A, Carver S. Parasit Vectors; 2016 Jun 02; 9(1):316. PubMed ID: 27255333 [Abstract] [Full Text] [Related]
16. Are humans the initial source of canine mange? Andriantsoanirina V, Fang F, Ariey F, Izri A, Foulet F, Botterel F, Bernigaud C, Chosidow O, Huang W, Guillot J, Durand R. Parasit Vectors; 2016 Mar 25; 9():177. PubMed ID: 27015813 [Abstract] [Full Text] [Related]
17. Treatment of canine sarcoptic mange with afoxolaner (NexGard®) and afoxolaner plus milbemycin oxime (NexGard Spectra®) chewable tablets: efficacy under field conditions in Portugal and Germany. Hampel V, Knaus M, Schäfer J, Beugnet F, Rehbein S. Parasite; 2018 Mar 25; 25():63. PubMed ID: 30516132 [Abstract] [Full Text] [Related]